Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 103 entries
Sorted by: Best Match Show Resources per page
Complete Genome Sequence of Cronobacter sakazakii Strain CMCC 45402.

Genome announcements

Zhao Z, Wang L, Wang B, Liang H, Ye Q, Zeng M.
PMID: 24435860
Genome Announc. 2014 Jan 16;2(1). doi: 10.1128/genomeA.01139-13.

Cronobacter sakazakii is considered to be an important pathogen involved in life-threatening neonatal infections. Here, we report the annotated complete genome sequence of C. sakazakii strain CMCC 45402, obtained from a milk sample in China. The major findings from...

Cite
Zhao Z, Wang L, Wang B, et al. Complete Genome Sequence of Cronobacter sakazakii Strain CMCC 45402. Genome Announc. 2014;2(1)doi: 10.1128/genomeA.01139-13.
Zhao, Z., Wang, L., Wang, B., Liang, H., Ye, Q., & Zeng, M. (2014). Complete Genome Sequence of Cronobacter sakazakii Strain CMCC 45402. Genome announcements, 2(1), . https://doi.org/10.1128/genomeA.01139-13
Zhao, Zhijing, et al. "Complete Genome Sequence of Cronobacter sakazakii Strain CMCC 45402." Genome announcements vol. 2,1 (2014). doi: https://doi.org/10.1128/genomeA.01139-13
Zhao Z, Wang L, Wang B, Liang H, Ye Q, Zeng M. Complete Genome Sequence of Cronobacter sakazakii Strain CMCC 45402. Genome Announc. 2014 Jan 16;2(1). doi: 10.1128/genomeA.01139-13. PMID: 24435860; PMCID: PMC3894274.
Copy Download .nbib Format: NLM
[Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products].

ALTEX

Pöbetanecker A, Cubetaler K.
PMID: 11178548
ALTEX. 1998;15(5):71-75.

The legal requirements for veterinary vaccines require the testing of each new vaccine batch for safety. In the European Pharmacopoeia a target animal safety test (TAST) is regularly required as a final product test for almost all vaccine batches....

Cite
Pöbetanecker A, Cubetaler K. Untersuchungen zur Relevanz der Prüfung auf spezifische Unschädlichkeit an der Zieltierspezies. Ergebnisse bei bakteriellen Impfstoffen im Zeitraum von 1994-1997. [Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products]. ALTEX. 1998;15(5):71-75
Pöbetanecker, A., & Cubetaler, K. (1998). Untersuchungen zur Relevanz der Prüfung auf spezifische Unschädlichkeit an der Zieltierspezies. Ergebnisse bei bakteriellen Impfstoffen im Zeitraum von 1994-1997. [Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products]. ALTEX, 15(5), 71-75.
Pöbetanecker, Angela, and Cubetaler, Klaus. "Untersuchungen zur Relevanz der Prüfung auf spezifische Unschädlichkeit an der Zieltierspezies. Ergebnisse bei bakteriellen Impfstoffen im Zeitraum von 1994-1997." [Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products]. ALTEX vol. 15,5 (1998): 71-75.
Pöbetanecker A, Cubetaler K. Untersuchungen zur Relevanz der Prüfung auf spezifische Unschädlichkeit an der Zieltierspezies. Ergebnisse bei bakteriellen Impfstoffen im Zeitraum von 1994-1997. [Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products]. ALTEX. 1998;15(5):71-75. PMID: 11178548.
Copy Download .nbib Format: NLM
Strategies for cancer therapy using carcinoembryonic antigen vaccines.

Expert reviews in molecular medicine

Hörig H, Medina FA, Conkright WA, Kaufman HL.
PMID: 14585140
Expert Rev Mol Med. 2000 Apr 19;2(3):1-24. doi: 10.1017/S146239940000168X.

Advances in molecular biology and immunology have renewed interest in the development of vaccines for the treatment or prevention of cancer. Research over the past 10 years has focused on the identification of suitable tumour antigens to use as...

Cite
Hörig H, Medina FA, Conkright WA, et al. Strategies for cancer therapy using carcinoembryonic antigen vaccines. Expert Rev Mol Med. 2000;2(3):1-24doi: 10.1017/S146239940000168X.
Hörig, H., Medina, F. A., Conkright, W. A., & Kaufman, H. L. (2000). Strategies for cancer therapy using carcinoembryonic antigen vaccines. Expert reviews in molecular medicine, 2(3), 1-24. https://doi.org/10.1017/S146239940000168X
Hörig, H, et al. "Strategies for cancer therapy using carcinoembryonic antigen vaccines." Expert reviews in molecular medicine vol. 2,3 (2000): 1-24. doi: https://doi.org/10.1017/S146239940000168X
Hörig H, Medina FA, Conkright WA, Kaufman HL. Strategies for cancer therapy using carcinoembryonic antigen vaccines. Expert Rev Mol Med. 2000 Apr 19;2(3):1-24. doi: 10.1017/S146239940000168X. PMID: 14585140.
Copy Download .nbib Format: NLM
APPLICATION OF VACCINES IN PUBLIC HEALTH WORK.

American journal of public health (New York, N.Y. : 1912)

McCoy GW.
PMID: 18010354
Am J Public Health (N Y). 1920 Aug;10(8):666-8. doi: 10.2105/ajph.10.8.666.

An important service to health officers is this dispassionate appraisal of the practical advantages of vaccines. They are useful, but constitute no royal road to health. Aside from antienteric vaccines and the toxin-antitoxin mixture public health administrators need expect...

Cite
McCoy GW. APPLICATION OF VACCINES IN PUBLIC HEALTH WORK. Am J Public Health (N Y). 1920;10(8):666-8doi: 10.2105/ajph.10.8.666.
McCoy, G. W. (1920). APPLICATION OF VACCINES IN PUBLIC HEALTH WORK. American journal of public health (New York, N.Y. : 1912), 10(8), 666-8. https://doi.org/10.2105/ajph.10.8.666
McCoy, G W. "APPLICATION OF VACCINES IN PUBLIC HEALTH WORK." American journal of public health (New York, N.Y. : 1912) vol. 10,8 (1920): 666-8. doi: https://doi.org/10.2105/ajph.10.8.666
McCoy GW. APPLICATION OF VACCINES IN PUBLIC HEALTH WORK. Am J Public Health (N Y). 1920 Aug;10(8):666-8. doi: 10.2105/ajph.10.8.666. PMID: 18010354; PMCID: PMC1362847.
Copy Download .nbib Format: NLM
A SIMPLE APPARATUS TO FACILITATE THE PREPARATION OF BACTERIAL VACCINES.

Science (New York, N.Y.)

Mishulow L.
PMID: 17809316
Science. 1936 Mar 06;83(2149):243-4. doi: 10.1126/science.83.2149.243.

No abstract available.

Cite
Mishulow L. A SIMPLE APPARATUS TO FACILITATE THE PREPARATION OF BACTERIAL VACCINES. Science. 1936;83(2149):243-4doi: 10.1126/science.83.2149.243.
Mishulow, L. (1936). A SIMPLE APPARATUS TO FACILITATE THE PREPARATION OF BACTERIAL VACCINES. Science (New York, N.Y.), 83(2149), 243-4. https://doi.org/10.1126/science.83.2149.243
Mishulow, L. "A SIMPLE APPARATUS TO FACILITATE THE PREPARATION OF BACTERIAL VACCINES." Science (New York, N.Y.) vol. 83,2149 (1936): 243-4. doi: https://doi.org/10.1126/science.83.2149.243
Mishulow L. A SIMPLE APPARATUS TO FACILITATE THE PREPARATION OF BACTERIAL VACCINES. Science. 1936 Mar 06;83(2149):243-4. doi: 10.1126/science.83.2149.243. PMID: 17809316.
Copy Download .nbib Format: NLM
The Treatment of Puerperal Septicaemia by Bacterial Vaccines.

Proceedings of the Royal Society of Medicine

Western GT.
PMID: 19976116
Proc R Soc Med. 1912;5:214-38.

No abstract available.

Cite
Western GT. The Treatment of Puerperal Septicaemia by Bacterial Vaccines. Proc R Soc Med. 1912;5:214-38
Western, G. T. (1912). The Treatment of Puerperal Septicaemia by Bacterial Vaccines. Proceedings of the Royal Society of Medicine, 5214-38.
Western, G T. "The Treatment of Puerperal Septicaemia by Bacterial Vaccines." Proceedings of the Royal Society of Medicine vol. 5 (1912): 214-38.
Western GT. The Treatment of Puerperal Septicaemia by Bacterial Vaccines. Proc R Soc Med. 1912;5:214-38. PMID: 19976116; PMCID: PMC2006266.
Copy Download .nbib Format: NLM
Remarks ON THE EFFECT OF BACTERIAL VACCINES ON NUTRITION.

British medical journal

Bruce LC.
PMID: 20764931
Br Med J. 1910 Feb 19;1(2564):430-2. doi: 10.1136/bmj.1.2564.430.

No abstract available.

Cite
Bruce LC. Remarks ON THE EFFECT OF BACTERIAL VACCINES ON NUTRITION. Br Med J. 1910;1(2564):430-2doi: 10.1136/bmj.1.2564.430.
Bruce, L. C. (1910). Remarks ON THE EFFECT OF BACTERIAL VACCINES ON NUTRITION. British medical journal, 1(2564), 430-2. https://doi.org/10.1136/bmj.1.2564.430
Bruce, L C. "Remarks ON THE EFFECT OF BACTERIAL VACCINES ON NUTRITION." British medical journal vol. 1,2564 (1910): 430-2. doi: https://doi.org/10.1136/bmj.1.2564.430
Bruce LC. Remarks ON THE EFFECT OF BACTERIAL VACCINES ON NUTRITION. Br Med J. 1910 Feb 19;1(2564):430-2. doi: 10.1136/bmj.1.2564.430. PMID: 20764931; PMCID: PMC2330451.
Copy Download .nbib Format: NLM
Immobilization of Pichia pastoris cells containing alcohol oxidase activity.

Iranian journal of microbiology

Maleknia S, Ahmadi H, Norouzian D.
PMID: 22530090
Iran J Microbiol. 2011 Dec;3(4):210-5.

BACKGROUND AND OBJECTIVES: The attempts were made to describe the development of a whole cell immobilization of P. pastoris by entrapping the cells in polyacrylamide gel beads. The alcohol oxidase activity of the whole cell Pichia pastoris was evaluated...

Cite
Maleknia S, Ahmadi H, Norouzian D. Immobilization of Pichia pastoris cells containing alcohol oxidase activity. Iran J Microbiol. 2011;3(4):210-5
Maleknia, S., Ahmadi, H., & Norouzian, D. (2011). Immobilization of Pichia pastoris cells containing alcohol oxidase activity. Iranian journal of microbiology, 3(4), 210-5.
Maleknia, S, et al. "Immobilization of Pichia pastoris cells containing alcohol oxidase activity." Iranian journal of microbiology vol. 3,4 (2011): 210-5.
Maleknia S, Ahmadi H, Norouzian D. Immobilization of Pichia pastoris cells containing alcohol oxidase activity. Iran J Microbiol. 2011 Dec;3(4):210-5. PMID: 22530090; PMCID: PMC3330185.
Copy Download .nbib Format: NLM
THE PROPHYLACTIC USE OF SENSITIZED BACTERIAL VACCINES IN PUERPERAL SEPSIS.

British medical journal

Champtaloup ST.
PMID: 20767158
Br Med J. 1914 Jun 06;1(2788):1221-4. doi: 10.1136/bmj.1.2788.1221.

No abstract available.

Cite
Champtaloup ST. THE PROPHYLACTIC USE OF SENSITIZED BACTERIAL VACCINES IN PUERPERAL SEPSIS. Br Med J. 1914;1(2788):1221-4doi: 10.1136/bmj.1.2788.1221.
Champtaloup, S. T. (1914). THE PROPHYLACTIC USE OF SENSITIZED BACTERIAL VACCINES IN PUERPERAL SEPSIS. British medical journal, 1(2788), 1221-4. https://doi.org/10.1136/bmj.1.2788.1221
Champtaloup, S T. "THE PROPHYLACTIC USE OF SENSITIZED BACTERIAL VACCINES IN PUERPERAL SEPSIS." British medical journal vol. 1,2788 (1914): 1221-4. doi: https://doi.org/10.1136/bmj.1.2788.1221
Champtaloup ST. THE PROPHYLACTIC USE OF SENSITIZED BACTERIAL VACCINES IN PUERPERAL SEPSIS. Br Med J. 1914 Jun 06;1(2788):1221-4. doi: 10.1136/bmj.1.2788.1221. PMID: 20767158; PMCID: PMC2301186.
Copy Download .nbib Format: NLM
Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients.

Avicenna journal of medical biotechnology

Haghighi F, Shahcheraghi F, Abbasi E, Eshraghi SS, Zeraati H, Mousavi SA, Asgarian-Omran H, Douraghi M, Shokri F.
PMID: 25215182
Avicenna J Med Biotechnol. 2014 Jul;6(3):178-84.

BACKGROUND: Re-emergence of pertussis has been reported in Iran despite a high rate of vaccination coverage. Low efficacy of the vaccine might be due to the genetic divergence between clinical versus vaccine strains. In the current study, the genetic...

Cite
Haghighi F, Shahcheraghi F, Abbasi E, et al. Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients. Avicenna J Med Biotechnol. 2014;6(3):178-84
Haghighi, F., Shahcheraghi, F., Abbasi, E., Eshraghi, S. S., Zeraati, H., Mousavi, S. A., Asgarian-Omran, H., Douraghi, M., & Shokri, F. (2014). Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients. Avicenna journal of medical biotechnology, 6(3), 178-84.
Haghighi, Faezeh, et al. "Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients." Avicenna journal of medical biotechnology vol. 6,3 (2014): 178-84.
Haghighi F, Shahcheraghi F, Abbasi E, Eshraghi SS, Zeraati H, Mousavi SA, Asgarian-Omran H, Douraghi M, Shokri F. Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients. Avicenna J Med Biotechnol. 2014 Jul;6(3):178-84. PMID: 25215182; PMCID: PMC4147105.
Copy Download .nbib Format: NLM
Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes.

Vaccines

Vitetta L, Saltzman ET, Thomsen M, Nikov T, Hall S.
PMID: 29232932
Vaccines (Basel). 2017 Dec 11;5(4). doi: 10.3390/vaccines5040050.

Immune defence against pathogenic agents comprises the basic premise for the administration of vaccines. Vaccinations have hence prevented millions of infectious illnesses, hospitalizations and mortality. Acquired immunity comprises antibody and cell mediated responses and is characterized by its specificity...

Cite
Vitetta L, Saltzman ET, Thomsen M, et al. Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes. Vaccines (Basel). 2017;5(4)doi: 10.3390/vaccines5040050.
Vitetta, L., Saltzman, E. T., Thomsen, M., Nikov, T., & Hall, S. (2017). Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes. Vaccines, 5(4), . https://doi.org/10.3390/vaccines5040050
Vitetta, Luis, et al. "Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes." Vaccines vol. 5,4 (2017). doi: https://doi.org/10.3390/vaccines5040050
Vitetta L, Saltzman ET, Thomsen M, Nikov T, Hall S. Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes. Vaccines (Basel). 2017 Dec 11;5(4). doi: 10.3390/vaccines5040050. PMID: 29232932; PMCID: PMC5748616.
Copy Download .nbib Format: NLM
High throughput nanoparticle tracking analysis for monitoring outer membrane vesicle production.

Journal of extracellular vesicles

Gerritzen MJH, Martens DE, Wijffels RH, Stork M.
PMID: 28717425
J Extracell Vesicles. 2017 Jun 19;6(1):1333883. doi: 10.1080/20013078.2017.1333883. eCollection 2017.

Outer membrane vesicles (OMVs) are spherical membrane nanoparticles released by Gram-negative bacteria. OMVs can be quantified in complex matrices by nanoparticle tracking analysis (NTA). NTA can be performed in static mode or with continuous sample flow that results in...

Cite
Gerritzen MJH, Martens DE, Wijffels RH, et al. High throughput nanoparticle tracking analysis for monitoring outer membrane vesicle production. J Extracell Vesicles. 2017;6(1):1333883doi: 10.1080/20013078.2017.1333883.
Gerritzen, M. J. H., Martens, D. E., Wijffels, R. H., & Stork, M. (2017). High throughput nanoparticle tracking analysis for monitoring outer membrane vesicle production. Journal of extracellular vesicles, 6(1), 1333883. https://doi.org/10.1080/20013078.2017.1333883
Gerritzen, Matthias J H, et al. "High throughput nanoparticle tracking analysis for monitoring outer membrane vesicle production." Journal of extracellular vesicles vol. 6,1 (2017): 1333883. doi: https://doi.org/10.1080/20013078.2017.1333883
Gerritzen MJH, Martens DE, Wijffels RH, Stork M. High throughput nanoparticle tracking analysis for monitoring outer membrane vesicle production. J Extracell Vesicles. 2017 Jun 19;6(1):1333883. doi: 10.1080/20013078.2017.1333883. eCollection 2017. PMID: 28717425; PMCID: PMC5505008.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 103 entries